TenQ · fact sheet · filings current to · price as of
Cigna (CI)
The business itself is the question here - 15 of 36 checks passed.
Latest close : $282.52, -1.3% on the day; -7.6% from the 52-week high. Refreshed every trading night.
Full analysis: report · all charts. Financial statements are computed from SEC EDGAR XBRL filings, current to . The share price and everything built on it (market cap, multiples, yields, the Value and Trend checks) are refreshed every trading night; this page shows the close of . Not investment advice.
Key figures
| Share price (delayed close) | $282.52 |
| Market cap | $74.7B |
| 52-week range | $240.32 - $305.80 |
| P/E | 11.8x |
| P/E, own 10-year median | 15.3x |
| P/S | 0.3x |
| Free cash flow yield | 12.4% |
| Dividend yield | 2.2% |
| Revenue (TTM) | $282.4B |
| Net income (TTM) | $6.4B |
| Free cash flow (TTM) | $9.2B |
| Gross margin | 20.6% |
| Operating margin | 3.5% |
| Return on equity | 15.1% |
| Revenue growth (1y) | +7.8% |
| Revenue CAGR (3y) | +15.0% |
| Debt / equity | 0.75x |
| Cash & short-term investments | $7.3B |
| Shares outstanding | 264.2m (cover page of the latest filing, 2026-07-24) |
The score: 15 of 36 checks passed
Six chapters, six pass/fail checks each. Five are computed from the filings; Trend is price behaviour, and says so.
Is CI stock cheap or expensive right now?
Value · 2 of 6 checks passed. Expensive against its own history and its sector - you're paying up for what you get. chapter →
Is Cigna still growing?
Growth · 3 of 6 checks passed. Growing, but with caveats - revenue +7.8% over the last year. chapter →
Does Cigna make real money?
Quality · 2 of 6 checks passed. Profitability is thin or negative - the growth isn't turning into money yet. chapter →
Can Cigna survive a bad year?
Health · 1 of 6 checks passed. The balance sheet carries real risk - read the checks before anything else. chapter →
What does Cigna hand back to shareholders?
Shareholder returns · 5 of 6 checks passed. Owners are paid reliably and affordably, and the share count is not eroding their stake. chapter →
Which way is CI trending?
Trend analysis · 2 of 6 checks passed. The market is voting against it right now - a falling trend on most measures. chapter →
Are insiders buying or selling CI?
Open-market buys: $0.00 · sells: $67M, across the recent Form 4 filings. detail →
Other insurance carriers we cover: Berkshire Hathaway (BRK-B) · UnitedHealth (UNH) · Progressive (PGR) · every company →
Method: figures computed deterministically from SEC EDGAR XBRL (companyfacts, frames, financial-statement-and-notes datasets, Form 4); prices delayed end-of-day. Scores count transparent pass/fail checks. Missing data is shown as missing, never estimated. Last changed . © TenQ - cite with a link to this page.